Virus-like particles (VLPs) are formed by the self-assembly of envelope and/or capsid
proteins from many viruses. In many cases such VLPs have structural characteristics and …

The immune system uses innate and adaptive immunity to recognize and combat foreign
agents that invade the body, but these methods are sometimes ineffective against human …

An effective virus-like particle (VLP) based prophylactic vaccine designed to protect against
persistent infection with human papillomavirus (HPV) types 16 and 18 and subsequent …

Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the
second most common cause of death from cancer among women worldwide. This Review …

Cancer of the uterine cervix is the second largest cause of cancer deaths in women, and its
toll is greatest in populations that lack screening programmes to detect precursor lesions …

The human papillomavirus (HPV) virus‐like particles (VLPs) produced by recombinant
expression systems are promising candidate vaccine antigens for prevention of cervical …

The baculovirus–insect cell expression system is an approved system for the production of
viral antigens with vaccine potential for humans and animals and has been used for …

Viruses-like particles (VLPs), assembled from capsid structural subunits of several different
viruses, have found a number of biomedical applications such as vaccines and novel …

Carcinoma of the uterine cervix, a leading cause of cancer death in women worldwide, is
initiated by infection with high‐risk types of human papillomaviruses (HPVs). This review …

The thermostability of GARDASIL®(Merck & Co., Inc, Whtehouse Station, NJ, USA), a
developmental vaccine against human papillomavirus (HPV), was evaluated using an …